![Yair Granot](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yair Granot
Amministratore Delegato presso Curesign Ltd
Posizioni attive di Yair Granot
Società | Posizione | Inizio | Fine |
---|---|---|---|
Curesign Ltd
![]() Curesign Ltd Medical SpecialtiesHealth Technology Curesign Ltd is a medical device company based in Tel Aviv, Israel. The Israeli company aims to revolutionize cancer treatment by integrating advanced sensors with signal processing and big data tools to create a patient-specific treatment plan for each cancer patient. The company's product is currently in advanced stages of development and has shown successful results in preclinical studies. The CEO of the company is Yair Granot. | Amministratore Delegato | - | - |
Storia della carriera di Yair Granot
Precedenti posizioni note di Yair Granot
Società | Posizione | Inizio | Fine |
---|---|---|---|
Essence Healthcare Ltd. | Direttore Tecnico/Scientifico/R&S | - | - |
SILVER CASTLE HOLDINGS LTD | Amministratore Delegato | 01/04/2016 | - |
Direttore Tecnico/Scientifico/R&S | 01/04/2016 | - |
Formazione di Yair Granot
University of California, Berkeley | Doctorate Degree |
Tel-Aviv University | Graduate Degree |
Statistiche
Distribuzione geografica
Israele | 5 |
Stati Uniti | 2 |
Posizioni
Chief Executive Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 3 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
SILVER CASTLE HOLDINGS LTD | Health Technology |
Aziende private | 2 |
---|---|
Essence Healthcare Ltd. | |
Curesign Ltd
![]() Curesign Ltd Medical SpecialtiesHealth Technology Curesign Ltd is a medical device company based in Tel Aviv, Israel. The Israeli company aims to revolutionize cancer treatment by integrating advanced sensors with signal processing and big data tools to create a patient-specific treatment plan for each cancer patient. The company's product is currently in advanced stages of development and has shown successful results in preclinical studies. The CEO of the company is Yair Granot. | Health Technology |
- Borsa valori
- Insiders
- Yair Granot
- Esperienza